The Lupus Alliance of LIQ is committed to supporting scientific and medical lupus research at local and national levels. One of Lupus Alliance of LIQ`s prime accomplishments has been to work collaboratively with the Lupus Research Institute (LRI) in its novel efforts to find better ways to treat and hopefully cure lupus. The Lupus Alliance of LIQ through your generous donations, has contributed over $550,000 to various research initiatives since 2002.


In the last few years, more funding has been directed at lupus research through government, for profit and non-profit organizations. For example, the National Institute of Health allocated $84 million in 2008 to fund lupus-related research. After so many years of under funding and unfocused attention in the research community, these initiatives are very encouraging.


There is a considerable amount of information on the web about lupus research. Keep coming back to our website to check out the latest information on research and related developments.

NIH to Fund Trial of Pill to Treat Lupus

Testing a new pill as a treatment lupus, an autoimmune disease estimated to affect 1.5 million people in the U.S., is the aim of a mid-stage trials being announced today by Corbus Pharmaceuticals and funded wholly by the federal government. Norwood-based Corbus (Nasdaq: CRBP) said this morning that the National Institutes of Health will foot… Read More »

Researchers of Lupus, Autoimmune Therapies May Soon Use the Wily Flu Virus to Help in Their Work

Researchers at Denmark’s Aarhus Research Center for Innate Immunology have discovered that the influenza virus has the ability to hide itself from the immune system due to a protein that masks its entrance into cells. This mechanism, besides providing knowledge about viral immune evasion and aiding in the development of new strategies to fight influenza, might also… Read More »

In Autoimmune Diseases Like Lupus, Researchers Discover Molecule that May Be Cause

A collaborative research project conducted between The Scripps Research Institute in La Jolla, California; Yale University  in New Haven, Connecticut; and National Biotechnology Center in Madrid, Spain, has identified a small molecule called miR-148a as a key regulator of immune cells, where higher levels appear to cause autoimmune diseases. The paper, “The microRNA miR-148a functions as a critical… Read More »

Immunovia, Lund University Receive $239K Grant to Validate Lupus Dx on Immray Platform

NEW YORK (GenomeWeb) – Swedish antibody array diagnostics firm Immunovia and Lund University have announced a SEK2 million ($239,300) grant from Vinnova, the Swedish Governmental Agency for Innovation Systems, to kick off validation of tests for lupus using the firm’s Immray technology platform. The antibody array-based tests will monitor an individual’s immune response by analysing… Read More »

Lupus Patients with Renal Failure Using Anticoagulants or Antiepileptics at Risk of Osteoporosis

Systemic lupus erythematosus (SLE) patients with chronic renal failure who are using anticoagulants or antiepileptics are at higher risk for osteoporosis and fragility fractures, according to a study, “Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus,” published in the journal Lupus Science & Medicine. Osteoporosis (OP) and fragility fractures (FFx) are a known… Read More »

Researchers Discover 10 New Lupus Genes in Asian Population Study

An international coalition of researchers led by Oklahoma Medical Research Foundation scientist Swapan Nath, Ph.D., has identified 10 new genes associated with the autoimmune disease lupus. The findings were published in the Jan. 25, 2016 issue of Nature Genetics. Nath and his colleagues analyzed more than17,000 human DNA samples collected from blood gathered from volunteers… Read More »

Lupuzor May Become First Non-Immunosuppressant Therapy for Lupus

LupuzorTM may become the first specific and non-immunosuppressant therapy for lupus, a disabling autoimmune disease that is currently incurable. Discovered by Sylviane Muller’s team in the CNRS Immunopathologie et Chimie Thérapeutique laboratory, in Strasbourg, this peptide is the subject of a CNRS patent (granted in 2009) and has already successfully completed phases I and II… Read More »

Researchers Answer Long-Standing Question About Lupus

For years, biomedical researchers have suspected that a specific set of immune cells are responsible for causing disease in lupus patients, but until now they haven’t known for sure one way or the other. A Virginia Tech immunologist has found that these cells—called plasmacytoid dendritic cells—do not, in fact, contribute to late-stage lupus in mice.… Read More »